Rules Based Medicine Obtains $25,000,000 Series A Round

  • Feed Type
  • Date
  • Company Name
    Rules Based Medicine
  • Mailing Address
    3300 Duval Road Austin, TX 78759
  • Company Description
    Rules-Based Medicine (RBM), the world’s leading multiplexed biomarker testing company, provides comprehensive protein biomarker products and services based on its Multi-Analyte Profiling (MAP) technology platform. RBM’s biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The financing will provide growth capital, debt repayment, and funding for acquisitions and investments to discover and validate biomarkers for medical diagnostics.
  • M&A Terms
  • Venture Investor
    Equity Group Investments
  • Venture Investor
    Cross Creek Capital
  • Venture Investor
    Syncom Venture Partners

Trending on Xconomy